TP53 and cancer: The early studies relied on a set of well-known cancer-associated genes (i.e., BRAF, TP53, RAS, etc.)and a general consensus on the characteristics of cancer cells, but whether these alterations are dominant in ATC or as subsequent phenomenon needs to be further confirmed.